Preoperative serum inflammatory markers in the prognostic assessment of hepatocellular carcinoma resection in stages I/II
- PMID: 40894075
- PMCID: PMC12394059
- DOI: 10.3389/fmolb.2025.1640390
Preoperative serum inflammatory markers in the prognostic assessment of hepatocellular carcinoma resection in stages I/II
Abstract
Background: Hepatocellular carcinoma (HCC) remains a global health challenge, with early-stage resection offering the best chance for improved outcomes. However, limitations of the TNM staging system highlight the need for additional prognostic tools. This study evaluates the prognostic value of preoperative serum inflammatory markers in patients with stage I/II HCC undergoing surgical resection.
Methods: A retrospective cohort study was conducted on 410 HCC patients (stage I/II) who underwent surgical resection at the Affiliated Hospital of North Sichuan Medical College between November 2011 and March 2020. Clinical and serological data, including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and platelet-to-neutrophil ratio (PNR), were analyzed. Prognostic factors for overall survival (OS) were identified through univariate and multivariate Cox regression analyses. A nomogram was developed to predict 1-year, 3-year, and 5-year OS, with its performance assessed using ROC curves, calibration plots, and decision curve analysis (DCA). Kaplan-Meier survival curves were used to compare risk groups, and the model's predictive efficacy was evaluated against the AJCC 8th Edition TNM staging system.
Results: Multivariate Cox regression identified NLR, PLR, ALBI score, AFP levels, and HBeAg status as independent prognostic factors for OS. The nomogram demonstrated superior discriminatory power (AUC: 0.78, 0.74, and 0.71 for 1-, 3-, and 5-year OS, respectively) compared to TNM staging. Kaplan-Meier analysis revealed significantly worse OS in the high-risk group (log-rank p < 0.001). The nomogram outperformed the AJCC TNM system in both discrimination and clinical utility, as validated by decision curve analysis and the Integrated Discrimination Improvement Index.
Conclusion: Preoperative serum inflammatory markers, when integrated with traditional TNM staging, significantly improve prognostic accuracy for stage I/II HCC patients undergoing surgical resection. The developed nomogram provides a practical tool for individualized risk stratification and may guide postoperative management to improve patient outcomes.
Keywords: hepatocellular carcinoma; nomogram; overall survival; prognostic assessment; serum inflammatory markers.
Copyright © 2025 Liu, Xiang, Xu and Xu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures







Similar articles
-
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23. Clin Orthop Relat Res. 2024. PMID: 39051924
-
Development and validation of a Log odds of negative lymph nodes/T stage ratio-based prognostic model for gastric cancer.Front Oncol. 2025 Jun 3;15:1554270. doi: 10.3389/fonc.2025.1554270. eCollection 2025. Front Oncol. 2025. PMID: 40530015 Free PMC article.
-
Development and validation of nomograms for predicting survival of locally advanced rectosigmoid junction cancer patients: a SEER database analysis.Transl Cancer Res. 2025 May 30;14(5):2808-2821. doi: 10.21037/tcr-24-1810. Epub 2025 May 27. Transl Cancer Res. 2025. PMID: 40530120 Free PMC article.
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
-
Postoperative adjuvant chemotherapy in rectal cancer operated for cure.Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD004078. doi: 10.1002/14651858.CD004078.pub2. Cochrane Database Syst Rev. 2012. PMID: 22419291 Free PMC article.
References
-
- Ahn J. C., Teng P.-C., Chen P.-J., Posadas E., Tseng H.-R., Lu S. C., et al. (2021). Detection of circulating tumor cells and their implications as a biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma. Hepatology 73, 422–436. 10.1002/hep.31165 - DOI - PMC - PubMed
-
- Antonarakis E. S., Feng Z., Trock B. J., Humphreys E. B., Carducci M. A., Partin A. W., et al. (2012). The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up. BJU Int. 109, 32–39. 10.1111/j.1464-410X.2011.10422.x - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources